Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amycretin - Novo Nordisk

Next Previous
X
Search
Drug Profile

Amycretin - Novo Nordisk

Alternative Names: NN-9847; NN9490 – Sc Amycretin; NNC-04870111

Latest Information Update: 22 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novo Nordisk
  • Class Obesity therapies; Peptide hormones
  • Mechanism of Action Amylin receptor agonists; Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Type 2 diabetes mellitus
  • Phase I Obesity

Most Recent Events

  • 20 Aug 2024 Novo Nordisk plans a phase I pharmacokinetics trial in Germany (SC) (NCT06559527)
  • 07 Aug 2024 Phase-II clinical trials in Type 2 diabetes mellitus (Treatment-experienced) in Spain, Slovakia, Romania, Poland, Japan, Hungary, Greece, Germany, Croatia, Bulgaria, USA (PO) (NCT06542874)
  • 07 Aug 2024 Phase-II clinical trials in Type 2 diabetes mellitus (Treatment-experienced) in Spain, Slovakia, Romania, Poland, Japan, Hungary, Greece, Germany, Croatia, Bulgaria, USA (SC) (NCT06542874)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top